ANG Lifesciences India Ltd.

Financial

	ANG Lifesciences	Deccan Health Care	Sandu Pharmaceutical
Operational Metrics
Financials
5 yr Average ROE	3.78 %	0.79 %	3.94 %
5yr average Equity Multiplier	3.3	1.17	1.34
5yr Average Asset Turnover Ratio	0.77	0.47	1.27
5yr Avg Net Profit Margin	-2.26 %	1.37 %	2.31 %
Price to Book	0.72	0.45	1.07
P/E	0.0	46.0	28.81
5yr Avg Cash Conversion Cycle	70.26 Days	218.27 Days	27.73 Days
Inventory Days	107.37 Days	372.92 Days	71.51 Days
Days Receivable	274.82 Days	54.52 Days	26.2 Days
Days Payable	235.98 Days	94.94 Days	79.23 Days
5yr Average Interest Coverage Ratio	1.81	12.96	28.27
5yr Avg ROCE	15.08 %	2.08 %	5.77 %
5yr Avg Operating Profit Margin	7.68 %	7.39 %	3.87 %
5 yr average Debt to Equity	0.97	0.02	0.0
5yr CAGR Net Profit	n/a	24.36 %	-1.69 %
5yr Average Return on Assets	1.04 %	0.68 %	2.94 %
Shareholdings
Promoter Holding	70.6 %	18.42 %	42.9 %
Share Pledged by Promoters	44.88 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	-0.55 %	-16.47 %	-7.53 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

Business

	ANG Lifesciences	Deccan Health Care	Sandu Pharmaceutical
Product Wise Break-Up	Product Wise Break-Up Nutraceuticals 0 Others 100	Product Wise Break-Up Nutraceuticals 100.0	Product Wise Break-Up Nutraceuticals 0 Others 100